aluates Reports

$ 0.0

Automative

Global Natural Killer Cell Therapy Market Research Report 2026

Published Date: 2026-02-25

Report Code: QYRE-Auto-38B12747

Global Natural Killer Cell Therapy Market Research Report 2023

BUY CHAPTERS

Global Natural Killer Cell Therapy Market Research Report 2026

Code: QYRE-Auto-38B12747

Report

2026-02-25

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Nektar Therapeutics

Innate Pharma SA

Affimed NV

Glycostem Therapeutics

Fate Therapeutics

Dragonfly Therapeutics

Nkarta Therapeutics

Natural Killer Cell Therapy Market Size

The global Natural Killer Cell Therapy market was valued at US$ 576 million in 2025 and is anticipated to reach US$ 1824 million by 2032, at a CAGR of 18.2% from 2026 to 2032.

Natural Killer Cell Therapy Market

Natural killer (NK) cell therapy is an emerging form of immunotherapy that utilizes the innate immune system’s natural killer cells to identify and destroy cancer cells or virally infected cells. NK cells are a type of lymphocyte capable of recognizing abnormal cells without prior sensitization, distinguishing them from normal healthy cells. In NK cell therapy, NK cells may be derived from the patient (autologous) or a donor (allogeneic), and can be expanded and activated in vitro before being infused into the patient. This therapy is being investigated for use in a range of cancers, including leukemia, lymphoma, and solid tumors, as well as in some infectious diseases.

The market for natural killer (NK) cell therapy is gaining significant momentum as part of the broader expansion of cellular immunotherapies. Unlike T-cell-based therapies, NK cell therapies offer advantages such as lower risk of graft-versus-host disease, shorter preparation time, and the potential for off-the-shelf products. These features have attracted interest from biotech companies, pharmaceutical firms, and academic research institutions. Numerous clinical trials are underway across North America, Europe, and Asia, exploring the efficacy of NK cell therapy in treating both hematologic malignancies and solid tumors. The combination of NK cells with other immunotherapies or genetic modifications, such as CAR-NK (chimeric antigen receptor-modified NK cells), is also showing promising results.

Key factors driving the market include increasing cancer incidence, growing investment in cell-based therapies, and advancements in NK cell expansion and engineering technologies. However, challenges remain, such as the limited persistence of NK cells in vivo and the complexity of large-scale manufacturing. Despite these hurdles, the outlook for the NK cell therapy market is optimistic, with strong support from regulatory agencies and continued scientific progress. As the demand for safer and more effective cancer treatments rises, NK cell therapy is expected to become a critical component of next-generation immuno-oncology strategies.

This report delivers a comprehensive overview of the global Natural Killer Cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Natural Killer Cell Therapy. The Natural Killer Cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Natural Killer Cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Natural Killer Cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Natural Killer Cell Therapy Market Report

Report Metric	Details
Report Name	Natural Killer Cell Therapy Market
Accounted market size in 2025	US$ 576 million
Forecasted market size in 2032	US$ 1824 million
CAGR	18.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	NK Cell Therapy CAR-NK Cell Therapy
Segment by Application	Cancer Infectious Diseases Gastrointestinal Diseases Beauty and Anti-Aging Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Nektar Therapeutics, ImmunityBio, Inc, GC Cell, Affimed, Innate Pharma SA, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Fortress Biotech, Nkure
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Natural Killer Cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Natural Killer Cell Therapy Market growing?

Ans: The Natural Killer Cell Therapy Market witnessing a CAGR of 18.2% during the forecast period 2026-2032.

What is the Natural Killer Cell Therapy Market size in 2032?

Ans: The Natural Killer Cell Therapy Market size in 2032 will be US$ 1824 million.

Who are the main players in the Natural Killer Cell Therapy Market report?

Ans: The main players in the Natural Killer Cell Therapy Market are Nektar Therapeutics, ImmunityBio, Inc, GC Cell, Affimed, Innate Pharma SA, Fate Therapeutics, Glycostem Therapeutics, Dragonfly Therapeutics, Nkarta Therapeutics, Fortress Biotech, Nkure

What are the Application segmentation covered in the Natural Killer Cell Therapy Market report?

Ans: The Applications covered in the Natural Killer Cell Therapy Market report are Cancer, Infectious Diseases, Gastrointestinal Diseases, Beauty and Anti-Aging, Others

What are the Type segmentation covered in the Natural Killer Cell Therapy Market report?

Ans: The Types covered in the Natural Killer Cell Therapy Market report are NK Cell Therapy, CAR-NK Cell Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer Cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 NK Cell Therapy

1.2.3 CAR-NK Cell Therapy

1.3 Market by Application

1.3.1 Global Natural Killer Cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Cancer

1.3.3 Infectious Diseases

1.3.4 Gastrointestinal Diseases

1.3.5 Beauty and Anti-Aging

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer Cell Therapy Market Perspective (2021–2032)

2.2 Global Natural Killer Cell Therapy Growth Trends by Region

2.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Natural Killer Cell Therapy Historic Market Size by Region (2021–2026)

2.2.3 Natural Killer Cell Therapy Forecasted Market Size by Region (2027–2032)

2.3 Natural Killer Cell Therapy Market Dynamics

2.3.1 Natural Killer Cell Therapy Industry Trends

2.3.2 Natural Killer Cell Therapy Market Drivers

2.3.3 Natural Killer Cell Therapy Market Challenges

2.3.4 Natural Killer Cell Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Natural Killer Cell Therapy Players by Revenue

3.1.1 Global Top Natural Killer Cell Therapy Players by Revenue (2021–2026)

3.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2021–2026)

3.2 Global Top Natural Killer Cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Natural Killer Cell Therapy Revenue

3.4 Global Natural Killer Cell Therapy Market Concentration Ratio

3.4.1 Global Natural Killer Cell Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapy Revenue in 2025

3.5 Global Key Players of Natural Killer Cell Therapy Head Offices and Areas Served

3.6 Global Key Players of Natural Killer Cell Therapy, Products and Applications

3.7 Global Key Players of Natural Killer Cell Therapy, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Natural Killer Cell Therapy Breakdown Data by Type

4.1 Global Natural Killer Cell Therapy Historic Market Size by Type (2021–2026)

4.2 Global Natural Killer Cell Therapy Forecasted Market Size by Type (2027–2032)

5 Natural Killer Cell Therapy Breakdown Data by Application

5.1 Global Natural Killer Cell Therapy Historic Market Size by Application (2021–2026)

5.2 Global Natural Killer Cell Therapy Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Natural Killer Cell Therapy Market Size (2021–2032)

6.2 North America Natural Killer Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Natural Killer Cell Therapy Market Size by Country (2021–2026)

6.4 North America Natural Killer Cell Therapy Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Natural Killer Cell Therapy Market Size (2021–2032)

7.2 Europe Natural Killer Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Natural Killer Cell Therapy Market Size by Country (2021–2026)

7.4 Europe Natural Killer Cell Therapy Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Natural Killer Cell Therapy Market Size (2021–2032)

8.2 Asia-Pacific Natural Killer Cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2021–2026)

8.4 Asia-Pacific Natural Killer Cell Therapy Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Natural Killer Cell Therapy Market Size (2021–2032)

9.2 Latin America Natural Killer Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Natural Killer Cell Therapy Market Size by Country (2021–2026)

9.4 Latin America Natural Killer Cell Therapy Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Natural Killer Cell Therapy Market Size (2021–2032)

10.2 Middle East & Africa Natural Killer Cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2021–2026)

10.4 Middle East & Africa Natural Killer Cell Therapy Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Nektar Therapeutics

11.1.1 Nektar Therapeutics Company Details

11.1.2 Nektar Therapeutics Business Overview

11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Introduction

11.1.4 Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.1.5 Nektar Therapeutics Recent Development

11.2 ImmunityBio, Inc

11.2.1 ImmunityBio, Inc Company Details

11.2.2 ImmunityBio, Inc Business Overview

11.2.3 ImmunityBio, Inc Natural Killer Cell Therapy Introduction

11.2.4 ImmunityBio, Inc Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.2.5 ImmunityBio, Inc Recent Development

11.3 GC Cell

11.3.1 GC Cell Company Details

11.3.2 GC Cell Business Overview

11.3.3 GC Cell Natural Killer Cell Therapy Introduction

11.3.4 GC Cell Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.3.5 GC Cell Recent Development

11.4 Affimed

11.4.1 Affimed Company Details

11.4.2 Affimed Business Overview

11.4.3 Affimed Natural Killer Cell Therapy Introduction

11.4.4 Affimed Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.4.5 Affimed Recent Development

11.5 Innate Pharma SA

11.5.1 Innate Pharma SA Company Details

11.5.2 Innate Pharma SA Business Overview

11.5.3 Innate Pharma SA Natural Killer Cell Therapy Introduction

11.5.4 Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.5.5 Innate Pharma SA Recent Development

11.6 Fate Therapeutics

11.6.1 Fate Therapeutics Company Details

11.6.2 Fate Therapeutics Business Overview

11.6.3 Fate Therapeutics Natural Killer Cell Therapy Introduction

11.6.4 Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.6.5 Fate Therapeutics Recent Development

11.7 Glycostem Therapeutics

11.7.1 Glycostem Therapeutics Company Details

11.7.2 Glycostem Therapeutics Business Overview

11.7.3 Glycostem Therapeutics Natural Killer Cell Therapy Introduction

11.7.4 Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.7.5 Glycostem Therapeutics Recent Development

11.8 Dragonfly Therapeutics

11.8.1 Dragonfly Therapeutics Company Details

11.8.2 Dragonfly Therapeutics Business Overview

11.8.3 Dragonfly Therapeutics Natural Killer Cell Therapy Introduction

11.8.4 Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.8.5 Dragonfly Therapeutics Recent Development

11.9 Nkarta Therapeutics

11.9.1 Nkarta Therapeutics Company Details

11.9.2 Nkarta Therapeutics Business Overview

11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Introduction

11.9.4 Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.9.5 Nkarta Therapeutics Recent Development

11.10 Fortress Biotech

11.10.1 Fortress Biotech Company Details

11.10.2 Fortress Biotech Business Overview

11.10.3 Fortress Biotech Natural Killer Cell Therapy Introduction

11.10.4 Fortress Biotech Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.10.5 Fortress Biotech Recent Development

11.11 Nkure

11.11.1 Nkure Company Details

11.11.2 Nkure Business Overview

11.11.3 Nkure Natural Killer Cell Therapy Introduction

11.11.4 Nkure Revenue in Natural Killer Cell Therapy Business (2021–2026)

11.11.5 Nkure Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Nektar Therapeutics

Innate Pharma SA

Affimed NV

Glycostem Therapeutics

Fate Therapeutics

Dragonfly Therapeutics

Nkarta Therapeutics

List of Tables

Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of NK Cell Therapy

Table 3. Key Players of CAR-NK Cell Therapy

Table 4. Global Natural Killer Cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Natural Killer Cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Natural Killer Cell Therapy Market Size by Region (US$ Million), 2021–2026

Table 7. Global Natural Killer Cell Therapy Market Share by Region (2021–2026)

Table 8. Global Natural Killer Cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Natural Killer Cell Therapy Market Share by Region (2027–2032)

Table 10. Natural Killer Cell Therapy Market Trends

Table 11. Natural Killer Cell Therapy Market Drivers

Table 12. Natural Killer Cell Therapy Market Challenges

Table 13. Natural Killer Cell Therapy Market Restraints

Table 14. Global Natural Killer Cell Therapy Revenue by Players (US$ Million), 2021–2026

Table 15. Global Natural Killer Cell Therapy Market Share by Players (2021–2026)

Table 16. Global Top Natural Killer Cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Natural Killer Cell Therapy Revenue, 2025

Table 17. Ranking of Global Top Natural Killer Cell Therapy Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapy Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Natural Killer Cell Therapy, Headquarters and Area Served

Table 20. Global Key Players of Natural Killer Cell Therapy, Products and Applications

Table 21. Global Key Players of Natural Killer Cell Therapy, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Natural Killer Cell Therapy Market Size by Type (US$ Million), 2021–2026

Table 24. Global Natural Killer Cell Therapy Revenue Market Share by Type (2021–2026)

Table 25. Global Natural Killer Cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Natural Killer Cell Therapy Revenue Market Share by Type (2027–2032)

Table 27. Global Natural Killer Cell Therapy Market Size by Application (US$ Million), 2021–2026

Table 28. Global Natural Killer Cell Therapy Revenue Market Share by Application (2021–2026)

Table 29. Global Natural Killer Cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Natural Killer Cell Therapy Revenue Market Share by Application (2027–2032)

Table 31. North America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Natural Killer Cell Therapy Market Size by Country (US$ Million), 2021–2026

Table 33. North America Natural Killer Cell Therapy Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Natural Killer Cell Therapy Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Natural Killer Cell Therapy Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Natural Killer Cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Natural Killer Cell Therapy Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Natural Killer Cell Therapy Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Natural Killer Cell Therapy Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Natural Killer Cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Natural Killer Cell Therapy Market Size by Country (US$ Million), 2027–2032

Table 46. Nektar Therapeutics Company Details

Table 47. Nektar Therapeutics Business Overview

Table 48. Nektar Therapeutics Natural Killer Cell Therapy Product

Table 49. Nektar Therapeutics Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 50. Nektar Therapeutics Recent Development

Table 51. ImmunityBio, Inc Company Details

Table 52. ImmunityBio, Inc Business Overview

Table 53. ImmunityBio, Inc Natural Killer Cell Therapy Product

Table 54. ImmunityBio, Inc Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 55. ImmunityBio, Inc Recent Development

Table 56. GC Cell Company Details

Table 57. GC Cell Business Overview

Table 58. GC Cell Natural Killer Cell Therapy Product

Table 59. GC Cell Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 60. GC Cell Recent Development

Table 61. Affimed Company Details

Table 62. Affimed Business Overview

Table 63. Affimed Natural Killer Cell Therapy Product

Table 64. Affimed Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 65. Affimed Recent Development

Table 66. Innate Pharma SA Company Details

Table 67. Innate Pharma SA Business Overview

Table 68. Innate Pharma SA Natural Killer Cell Therapy Product

Table 69. Innate Pharma SA Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 70. Innate Pharma SA Recent Development

Table 71. Fate Therapeutics Company Details

Table 72. Fate Therapeutics Business Overview

Table 73. Fate Therapeutics Natural Killer Cell Therapy Product

Table 74. Fate Therapeutics Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 75. Fate Therapeutics Recent Development

Table 76. Glycostem Therapeutics Company Details

Table 77. Glycostem Therapeutics Business Overview

Table 78. Glycostem Therapeutics Natural Killer Cell Therapy Product

Table 79. Glycostem Therapeutics Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 80. Glycostem Therapeutics Recent Development

Table 81. Dragonfly Therapeutics Company Details

Table 82. Dragonfly Therapeutics Business Overview

Table 83. Dragonfly Therapeutics Natural Killer Cell Therapy Product

Table 84. Dragonfly Therapeutics Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 85. Dragonfly Therapeutics Recent Development

Table 86. Nkarta Therapeutics Company Details

Table 87. Nkarta Therapeutics Business Overview

Table 88. Nkarta Therapeutics Natural Killer Cell Therapy Product

Table 89. Nkarta Therapeutics Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 90. Nkarta Therapeutics Recent Development

Table 91. Fortress Biotech Company Details

Table 92. Fortress Biotech Business Overview

Table 93. Fortress Biotech Natural Killer Cell Therapy Product

Table 94. Fortress Biotech Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 95. Fortress Biotech Recent Development

Table 96. Nkure Company Details

Table 97. Nkure Business Overview

Table 98. Nkure Natural Killer Cell Therapy Product

Table 99. Nkure Revenue in Natural Killer Cell Therapy Business (US$ Million), 2021–2026

Table 100. Nkure Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Natural Killer Cell Therapy Picture

Figure 2. Global Natural Killer Cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Natural Killer Cell Therapy Market Share by Type: 2025 vs 2032

Figure 4. NK Cell Therapy Features

Figure 5. CAR-NK Cell Therapy Features

Figure 6. Global Natural Killer Cell Therapy Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Natural Killer Cell Therapy Market Share by Application: 2025 vs 2032

Figure 8. Cancer Case Studies

Figure 9. Infectious Diseases Case Studies

Figure 10. Gastrointestinal Diseases Case Studies

Figure 11. Beauty and Anti-Aging Case Studies

Figure 12. Others Case Studies

Figure 13. Natural Killer Cell Therapy Report Years Considered

Figure 14. Global Natural Killer Cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 15. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Natural Killer Cell Therapy Market Share by Region: 2025 vs 2032

Figure 17. Global Natural Killer Cell Therapy Market Share by Players in 2025

Figure 18. Global Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapy Revenue in 2025

Figure 20. North America Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. North America Natural Killer Cell Therapy Market Share by Country (2021–2032)

Figure 22. United States Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Canada Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. Europe Natural Killer Cell Therapy Market Share by Country (2021–2032)

Figure 26. Germany Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. France Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. U.K. Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Italy Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Russia Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Ireland Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Asia-Pacific Natural Killer Cell Therapy Market Share by Region (2021–2032)

Figure 34. China Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Japan Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. South Korea Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Southeast Asia Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. India Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Australia & New Zealand Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Latin America Natural Killer Cell Therapy Market Share by Country (2021–2032)

Figure 42. Mexico Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Brazil Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Middle East & Africa Natural Killer Cell Therapy Market Share by Country (2021–2032)

Figure 46. Israel Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Saudi Arabia Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. UAE Natural Killer Cell Therapy Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Nektar Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 50. ImmunityBio, Inc Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 51. GC Cell Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 52. Affimed Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 53. Innate Pharma SA Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 54. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 55. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 56. Dragonfly Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 57. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 58. Fortress Biotech Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 59. Nkure Revenue Growth Rate in Natural Killer Cell Therapy Business (2021–2026)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global NK Cell Therapy Market Insights Forecast to 2030

Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Natural Killer Cell Therapeutics Market Research Report 2024

Global Cell Therapy Market Insights Forecast to 2030

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Global Cancer Biotherapy Market Insights Forecast to 2030

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Therapy Market Insights Forecast to 2030

Global Immuno oncology Therapy Market Insights Forecast to 2030

Global Immunocell Therapy Market Insights Forecast to 2030

Global Cytotherapy Market Insights Forecast to 2030

Global Stem Cell Treatments Market Insights Forecast to 2030

Global Immuno Cell Therapy Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Cell Transplantatio Therapy Market Insights Forecast to 2030

Global Autologous Cell Therapy Market Insights Forecast to 2030

Global Cellular Therapy CT Market Insights Forecast to 2030

Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030

Global Cell Therapy Regenerative Medicine Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions